| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,700,000 | 7,566,000 | 7,570,000 | 8,712,000 | | Cost of Revenue | 5,797,000 | 5,682,000 | 5,756,000 | 6,523,000 | | | Gross Profit | 1,903,000 | 1,884,000 | 1,814,000 | 2,189,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,048,000 | 1,084,000 | 1,152,000 | 1,179,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 855,000 | 800,000 | 662,000 | 1,010,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 68,000 | (66,000) | (2,000) | (2,000) | | Earnings Before Interest And Taxes | 908,000 | 749,000 | 660,000 | 1,022,000 | | Interest Expense | 110,000 | 123,000 | 117,000 | 114,000 | | Income Before Tax | 798,000 | 626,000 | 543,000 | 908,000 | | Income Tax Expense | 179,000 | 166,000 | 144,000 | 201,000 | | Minority Interest | (11,000) | (10,000) | (2,000) |
-
| | | | Net Income From Continuing Ops | 608,000 | 450,000 | 397,000 | 707,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 608,000 | 450,000 | 397,000 | 707,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $608,000 | $450,000 | $397,000 | $707,000 |
|
0.11% Nasdaq 0.00%
Income Statement
